Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 93301-93350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04942834
Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation
NARecruiting
286 participants
Started: Oct 1, 2021 · Completed: Jan 31, 2026
2 conditions1 sponsor17 locations
NCT05066087
Digital Behavioural Treatment for Chronic Pain
NAEnrolling by invitation
410 participants
Started: Oct 1, 2021 · Completed: Dec 30, 2025
1 condition4 sponsors4 locations
NCT04989725
Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer
PHASE2Recruiting
46 participants
Started: Oct 1, 2021 · Completed: Dec 1, 2027
3 conditions1 sponsor1 location
NCT05273216
Reperfusion Injury After Endovascular Stroke Treatment
N/ARecruiting
600 participants
Started: Oct 1, 2021 · Completed: Jul 31, 2026
1 condition3 sponsors3 locations
NCT05142202
High Five (HiFi) Accelerated Partial Breast Irradiation Study
NAActive, not recruiting
147 participants
Started: Oct 1, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07019935
Afterload Mismatch Predictive modLE for Transcatheter Edge-to-Edge Repair (AMPLE-TEER)
N/ARecruiting
1,000 participants
Started: Oct 1, 2021 · Completed: Oct 1, 2030
1 condition1 sponsor1 location
NCT04968743
Phase-dependent Evaluation of Motor Cortex Excitability With TMS in Stroke
NARecruiting
72 participants
Started: Oct 1, 2021 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT05271435
Digital Tools for Assessment of Motor Functions and Falls in ALS
N/AActive, not recruiting
20 participants
Started: Oct 1, 2021 · Completed: Sep 30, 2025
3 conditions2 sponsors1 location
NCT04655235
Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia
N/ARecruiting
600 participants
Started: Oct 1, 2021 · Completed: Mar 31, 2030
1 condition1 sponsor3 locations
NCT05557474
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
N/ARecruiting
236 participants
Started: Oct 1, 2021 · Completed: Dec 31, 2028
3 conditions2 sponsors2 locations
NCT06181175
Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial
NARecruiting
250 participants
Started: Oct 1, 2021 · Completed: Apr 30, 2025
3 conditions1 sponsor1 location
NCT05335421
Mindfulness and Hip Preservation Surgery
NAEnrolling by invitation
200 participants
Started: Oct 1, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05205551
Prospera Test Evaluation in Cardiac Transplant (ProTECT)
N/AActive, not recruiting
411 participants
Started: Oct 1, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05099341
DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls
NARecruiting
90 participants
Started: Oct 1, 2021 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05627739
A Study of Mycophenolate Mofetil Combined With Glucocorticoid Therapy in Relapse Vogt-Koyanagi-Harada Disease
N/ARecruiting
15 participants
Started: Oct 1, 2021 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05009225
Clinical Decision Support for Atrial Fibrillation and Flutter
N/AActive, not recruiting
4,000 participants
Started: Oct 1, 2021 · Completed: Jun 30, 2024
1 condition1 sponsor16 locations
NCT05645081
Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
N/ARecruiting
360 participants
Started: Oct 1, 2021 · Completed: Sep 1, 2027
3 conditions2 sponsors1 location
NCT05125055
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
PHASE2/PHASE3Recruiting
80 participants
Started: Oct 1, 2021 · Completed: Dec 30, 2026
4 conditions1 sponsor1 location
NCT05870267
Biomechanical Assessment of Load Applied on Residuum of Individuals With Limb Loss Fitted With a Prosthetic Limb
N/ARecruiting
20 participants
Started: Oct 1, 2021 · Completed: Jun 30, 2024
2 conditions2 sponsors1 location
NCT05047536
KZR-261 in Subjects With Advanced Solid Malignancies
PHASE1Active, not recruiting
61 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor12 locations
NCT04798651
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
NARecruiting
150 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2026
2 conditions2 sponsors1 location
NCT05024045
Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
PHASE1Active, not recruiting
316 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
7 conditions1 sponsor23 locations
NCT04880031
A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension
PHASE2Active, not recruiting
231 participants
Started: Sep 30, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors48 locations
NCT04251377
Single-stage Surgery With Antibiotic-loaded Hydrogel Coated Implants Versus Two Stage Surgery for Secondary Prevention of Complex Chronic Periprosthetic Hip Joint Infection
NARecruiting
440 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors14 locations
NCT04566497
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
NARecruiting
2,664 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT05009537
Optical Genome Mapping in Hematological Malignancies
N/ARecruiting
200 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2026
3 conditions1 sponsor4 locations
NCT04986852
Olinvacimab With Pembrolizumab in Patients With mTNBC
PHASE2Recruiting
30 participants
Started: Sep 30, 2021 · Completed: Aug 30, 2026
1 condition2 sponsors1 location
NCT05061732
Helicobacter Pylori Eradication and Follow-up
PHASE4Recruiting
4,447 participants
Started: Sep 30, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT03620266
Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
NARecruiting
900 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
1 condition9 sponsors8 locations
NCT05015686
Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old
PHASE3Enrolling by invitation
2,400 participants
Started: Sep 30, 2021 · Completed: Sep 20, 2026
1 condition1 sponsor1 location
NCT04985760
Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy
PHASE1Active, not recruiting
32 participants
Started: Sep 30, 2021 · Completed: Nov 28, 2025
1 condition2 sponsors2 locations
NCT05065593
The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis
NAActive, not recruiting
26 participants
Started: Sep 30, 2021 · Completed: Jan 30, 2025
1 condition1 sponsor1 location
NCT04851678
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
N/ARecruiting
140 participants
Started: Sep 30, 2021 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT04583124
Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)
NARecruiting
56 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05006963
Tele-Rehabilitation in Patients With Temporomandibular Dysfunction
NARecruiting
50 participants
Started: Sep 30, 2021 · Completed: Mar 30, 2027
3 conditions1 sponsor1 location
NCT05321407
COVID-19 Vaccine Responses in PIDD Subjects
N/AActive, not recruiting
100 participants
Started: Sep 30, 2021 · Completed: Jul 31, 2026
7 conditions5 sponsors3 locations
NCT04904588
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
PHASE2Active, not recruiting
300 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
8 conditions2 sponsors39 locations
NCT04828382
Prospective Study of Pregnancy in Women with Cystic Fibrosis
N/AActive, not recruiting
285 participants
Started: Sep 30, 2021 · Completed: Dec 30, 2026
2 conditions4 sponsors40 locations
NCT04965090
A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)
PHASE2Active, not recruiting
43 participants
Started: Sep 30, 2021 · Completed: Jul 31, 2026
2 conditions2 sponsors7 locations
NCT05019846
SRT Versus SRT+ADT in Prostate Cancer
PHASE3Recruiting
310 participants
Started: Sep 30, 2021 · Completed: Dec 1, 2029
1 condition2 sponsors1 location
NCT04987138
Safety and Effectiveness Study of the Zenflow Spring System
NAActive, not recruiting
279 participants
Started: Sep 30, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor7 locations
NCT05100017
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
NARecruiting
126 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05041907
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
PHASE2Recruiting
3,800 participants
Started: Sep 30, 2021 · Completed: Jan 31, 2027
1 condition1 sponsor7 locations
NCT05419713
Intermediate Visual Space Perception
NARecruiting
180 participants
Started: Sep 30, 2021 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT04603807
A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases
PHASE3Recruiting
220 participants
Started: Sep 30, 2021 · Completed: Jun 26, 2028
1 condition1 sponsor91 locations
NCT04384601
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
PHASE3Not yet recruiting
246 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT04977765
Cardiometabolic Health in Transgender Males
N/AActive, not recruiting
90 participants
Started: Sep 30, 2021 · Completed: Aug 1, 2027
2 conditions2 sponsors1 location
NCT05024383
Dissecting the Heterogeneity of Oral Cancer Pain
NARecruiting
80 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04995159
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
NANot yet recruiting
2,150 participants
Started: Sep 30, 2021 · Completed: Jan 31, 2028
1 condition1 sponsor114 locations
NCT05028933
IMC001 for Clinical Research on Advanced Digestive System Malignancies
PHASE1Recruiting
48 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2024
4 conditions1 sponsor2 locations